Analysts at William Blair believe dapiglutide’s 11.6% weight reduction could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.
Analysts at William Blair believe dapiglutide’s 11.6% weight reduction could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.